Transcript:
I’ve joined companies both blueprint medicines and score therapeutics is one of the first employees with no infrastructure in place. So I have with chemists and biologists evaluated products on the markets and the conclusion both times was that Certara three sixty really is the best product out there.
When you just ask a scientist, please share your data. They don’t know how to do it or their incentives are not quite there. And so having a tool like the three sixty enabled that incentive to sort of be aligned. And then the consumers could actually now get the data and have the conversation about on the same place.
When you’re joining data from a lot of different sources, it can be pretty complicated to essentially get a spreadsheet where you’ve got value in every column. And the the big thing that was a draw for us was how well it made what was essentially a broad data structure feel tall and skinny to users.
I guess I would comment on the people. Honestly, at Certara, I think everyone that I’ve talked to and worked with just has been so welcoming and so kind and honestly an and what they do.
You could probably extract a lot of cost savings on experiments not repeated in ways to experiments, knowing where to hunt. It’s like minesweeper, you’re not just hitting the wrong spot and blowing up, you are getting closer to the right spot when you are using the tooling that DTC provides.
Having multiple separate systems is one thing that we’ve really struggled with. And so I think unifying our data visualization platform and tool with p three six see is tremendous, and I think it’s gonna have tremendous capabilities in the future as well.
